Blog
EQS-Adhoc: Andritz AG resolves on a new share buyback program
EQS-Adhoc: Andritz AG resolves on a new share buyback program
EQS-Adhoc: Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024
EQS-Adhoc: Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024
EQS-News: Andy Halford appointed as Aareal Bank’s new Chief Financial Officer
EQS-News: Andy Halford appointed as Aareal Bank’s new Chief Financial Officer
u-blox high-precision positioning solutions now available on NVIDIA® Jetson™ Edge AI and NVIDIA DRIVE Hyperion™ platforms
u-blox high-precision positioning solutions now available on NVIDIA® Jetson™ Edge AI and NVIDIA DRIVE Hyperion™ platforms
EQS-Adhoc: BP p.l.c.: 2Q24 SEA Part 1 of 1
EQS-Adhoc: BP p.l.c.: 2Q24 SEA Part 1 of 1
Molten Ventures Plc: Transaction in own shares
Molten Ventures Plc: Transaction in own shares
EQS-News: Biotest increases sales in the first half of 2024 by 35% to Euro 372 million
EQS-News: Biotest increases sales in the first half of 2024 by 35% to Euro 372 million
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
EQS-News: Basler AG acquires remaining shares of i2S's distribution business
EQS-News: Basler AG acquires remaining shares of i2S's distribution business
EQS-News: The NAGA Group: Research update from SMC available – Upgrade to “BUY” recommendation and price target raised to EUR 1.60
EQS-News: The NAGA Group: Research update from SMC available – Upgrade to “BUY” recommendation and price target raised to EUR 1.60
EQS-News: RBI: Semi-Annual Financial Report 2024 - Stable performance in the core business
EQS-News: RBI: Semi-Annual Financial Report 2024 - Stable performance in the core business
AEVIS VICTORIA SA (AEVS:SW) achieved revenues of more than CHF 450 million in the first half-year 2024
AEVIS VICTORIA SA (AEVS:SW) achieved revenues of more than CHF 450 million in the first half-year 2024
SIG Group AG: Quarter on quarter sequential improvement across KPIs
SIG Group AG: Quarter on quarter sequential improvement across KPIs
EQS-News: FUCHS with good first half of 2024
EQS-News: FUCHS with good first half of 2024
EQS-News: Formycon announces start of clinical phase III trial for Keytruda® biosimilar candidate FYB206
EQS-News: Formycon announces start of clinical phase III trial for Keytruda® biosimilar candidate FYB206
Avolta reports strong H1 turnover growth of +11% with uninterrupted positive momentum into H2
Avolta reports strong H1 turnover growth of +11% with uninterrupted positive momentum into H2
Kardex Holding AG: Half-Year Results 2024
Kardex Holding AG: Half-Year Results 2024
EQS-News: Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin.
EQS-News: Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin.
EQS-News: LM Pay S.A. Shareholder General Meeting Report
EQS-News: LM Pay S.A. Shareholder General Meeting Report
Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC: Transaction in own shares
Lalique Group applies for delisting of its shares
Lalique Group applies for delisting of its shares
Funding Circle Plc: POS-Transaction in Own Shares
Funding Circle Plc: POS-Transaction in Own Shares
EQS-News: CANCOM SE: Voluntary public share buyback offer 2024 successfully completed
EQS-News: CANCOM SE: Voluntary public share buyback offer 2024 successfully completed
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse publishes preliminary results for the second quarter of 2024 and raises guidance
EQS-News: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse publishes preliminary results for the second quarter of 2024 and raises guidance
EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Publishes Preliminary Financial Figures for the Second Quarter of 2024 and Raises Guidance for 2024
EQS-Adhoc: Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Publishes Preliminary Financial Figures for the Second Quarter of 2024 and Raises Guidance for 2024


